Here is the interim analysis of the pembrolizumab combo study at UCLA. The survival data are already astonishing! You simply cannot say that the living are dead—it’s an easy fact to prove!
We have already seen some of Dr. Linda Liau's and her team's work. Per your comment "Let's see what the real data is on the GBM Keytruda combo trial" All is good.